IMPACT OF OZANIMOD (OZA) ON C-REACTIVE PROTEIN (CRP) LEVELS AND THE ASSOCIATION WITH OZA EFFICACY IN PATIENTS (PTS) WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS (UC): RESULTS FROM THE PHASE 3 TRUE NORTH (TN) STUDY

Sarah Harris  ¹     Rachel Maddux  ¹     Chun Wu  ¹     Yanhua Hu  ¹     AnnKatrin Petersen  ¹     David T. Rubin  ^2    
1 Bristol Myers Squibb, Princeton, United States
² University of Chicago Medicine, Inflammatory Bowel Disease Center, Chicago, United States

Topic
IBD

Session
PP 05 IBD (Posters)

Conference
UEG Week 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)